Aquilo Capital Management, LLC

CIK

1591986

Location

SAN FRANCISCO, CA

Portfolio Value

Micro $45,218,694

Diversification

Moderately concentrated

Filing Date

Global Rank

#6,465 / 7,977 ▼ 24

Top Industry

Biotechnology 58.7%

3Y Alpha vs SPY

-7.0%

Period ended 1 year ago

Filed May 15, 2025 · 1y

21 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+47.5%

SPY

+76.3%

Annualised alpha

-7.0%

Max drawdown

−74.2%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

10 positions · as of Mar 31, 2025 · Δ vs Dec 31, 2024

Top Position

41.3%

+12.4 pts

Top 5

81.6%

+6.9 pts

Top 10

100.0%

0.0 pts

HHI

2,229

Moderately concentrated+698

Portfolio Trend

21 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2025

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$45,218,694	10

Last Quarter's Activity

Export CSV

Mar 31, 2025 vs Dec 31, 2024

Added To

Positions the filer increased

4 positions

Ticker	Company	Δ Shares	Shares	Value
DTIL	Precision Biosciences Inc	+189,773	726,149	$3,463,730
AMGN	Amgen Inc	+35,000	60,000	$18,693,000
ARVN	Arvinas, Inc.	+32,000	360,766	$2,532,577
PTGX	Protagonist Therapeutics, Inc	+5,100	81,692	$3,950,625
No positions match the current search.

Trimmed

Positions the filer reduced

5 positions

Ticker	Company	Δ Shares	Shares	Value
ARWR	Arrowhead Pharmaceuticals, Inc.	−232,459	550,130	$7,008,656
RGNX	REGENXBIO Inc.	−75,000	271,302	$1,939,809
IMTX	Immatics N.V.	−69,000	304,902	$1,375,108
BCYC	Bicycle Therapeutics PLC	−50,216	171,695	$1,457,690
KYMR	Kymera Therapeutics, Inc.	−45,000	138,521	$3,791,319
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
ZYME	Zymeworks Inc.	84,482	$1,006,180
No positions match the current search.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
SLN	Silence Therapeutics plc	367,214	$2,526,432
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

10 positions · $45,218,694 total · as of Mar 31, 2025

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
AMGN	Amgen Inc Healthcare	Added	60,000	+35,000	$18,693,000	+186.9%	41.34%
ARWR	Arrowhead Pharmaceuticals, Inc. Healthcare	Reduced	550,130	-232,459	$7,008,656	−52.4%	15.50%
PTGX	Protagonist Therapeutics, Inc Healthcare	Added	81,692	+5,100	$3,950,625	+33.6%	8.74%
KYMR	Kymera Therapeutics, Inc. Healthcare	Reduced	138,521	-45,000	$3,791,319	−48.6%	8.38%
DTIL	Precision Biosciences Inc Healthcare	Reduced	726,149	-602,089	$3,463,730	−31.6%	7.66%
ARVN	Arvinas, Inc. Healthcare	Added	360,766	+32,000	$2,532,577	−59.8%	5.60%
RGNX	REGENXBIO Inc. Healthcare	Reduced	271,302	-75,000	$1,939,809	−27.5%	4.29%
BCYC	Bicycle Therapeutics PLC Healthcare	Reduced	171,695	-50,216	$1,457,690	−53.1%	3.22%
IMTX	Immatics N.V. Healthcare	Reduced	304,902	-69,000	$1,375,108	−48.3%	3.04%
ZYME	Zymeworks Inc. Healthcare	NEW	84,482	NEW	$1,006,180	NEW	2.23%